Affiliation:
1. Fujian University of Traditional Chinese Medicine
Abstract
Abstract
Knee osteoarthritis (KOA) patients often suffer from cognitive decline. This study aims to investigate the relationship between cognitive decline, hippocampal subregions, and serum inflammatory cytokines levels in KOA. Their correlation and mediating effects were analyzed. Cognitive function declined at follow-up, and the decline was more pronounced in the AD8>1 group. The fimbria volume decreased in the AD8>1 group, while increased in the AD8≤1 group. The fimbria volume was correlated with cognitive performance in both group. Brain-derived neurotrophic factor (BDNF) levels were negatively correlated with the Montreal Cognitive Assessment_Language (MoCA_Language) subscore change in the AD8≤1 group and Recombinant Cannabinoid Receptor 2 (CNR2) levels were negatively correlated with the Wechsler Memory Scale – Chinese Revision_1-100 (WMS-CR_1-100) subscore change in the AD8>1 group. In addition, the serum Interferon-gamma (IFN-γ) level was a protective factor against cognitive decline and the fimbria volume played a mediating role between pain, T cell immunoglobulin domain and mucin domain 3 (TIM3) /IFN-γ levels, and the WMS-CR_1-100 subscore. Our results suggested that the fimbria was an important mediator of cognitive decline in KOA, and CNR1, CNR2, and BDNF were strongly associated with cognitive decline while IFN-γ levels may be a protective factor against cognitive progression in KOA.
Clinical trial registration number: ChiCTR-IOR-16009308
Publisher
Research Square Platform LLC
Reference50 articles.
1. Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy;Abate G;Biology (Basel),2021
2. Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging;Albayram O;Proc Natl Acad Sci U S A,2011
3. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association;Altman R;Arthritis And Rheumatism,1986
4. Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease: Results from a cross-sectional study;Beauchet O;Experimental Gerontology,2019
5. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee;Bellamy N;Journal Of Rheumatology,1988